- Home
- TSHA vs WRLD Comparison
TSHA vs WRLD Comparison
Compare TSHA & WRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- WRLD
- Stock Information
- Founded
- TSHA 2019
- WRLD 1962
- Country
- TSHA United States
- WRLD United States
- Employees
- TSHA N/A
- WRLD N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- WRLD Finance: Consumer Services
- Sector
- TSHA Health Care
- WRLD Finance
- Exchange
- TSHA Nasdaq
- WRLD Nasdaq
- Market Cap
- TSHA 728.4M
- WRLD 859.5M
- IPO Year
- TSHA 2020
- WRLD 1991
- Fundamental
- Price
- TSHA $3.36
- WRLD $173.01
- Analyst Decision
- TSHA Strong Buy
- WRLD
- Analyst Count
- TSHA 7
- WRLD 0
- Target Price
- TSHA $8.71
- WRLD N/A
- AVG Volume (30 Days)
- TSHA 3.5M
- WRLD 40.7K
- Earning Date
- TSHA 08-12-2025
- WRLD 10-24-2025
- Dividend Yield
- TSHA N/A
- WRLD N/A
- EPS Growth
- TSHA N/A
- WRLD 10.95
- EPS
- TSHA N/A
- WRLD 14.92
- Revenue
- TSHA $8,098,000.00
- WRLD $567,706,032.00
- Revenue This Year
- TSHA N/A
- WRLD N/A
- Revenue Next Year
- TSHA N/A
- WRLD $3.55
- P/E Ratio
- TSHA N/A
- WRLD $11.60
- Revenue Growth
- TSHA N/A
- WRLD 0.80
- 52 Week Low
- TSHA $1.05
- WRLD $104.99
- 52 Week High
- TSHA $3.40
- WRLD $177.25
- Technical
- Relative Strength Index (RSI)
- TSHA 70.13
- WRLD 56.58
- Support Level
- TSHA $2.79
- WRLD $165.28
- Resistance Level
- TSHA $2.99
- WRLD $174.51
- Average True Range (ATR)
- TSHA 0.16
- WRLD 4.92
- MACD
- TSHA 0.03
- WRLD 0.41
- Stochastic Oscillator
- TSHA 93.71
- WRLD 82.66
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About WRLD World Acceptance Corporation
World Acceptance Corp operates a small-loan consumer finance business. The company offers short-term small installment loans, medium-term larger installment loans, related credit insurance and ancillary products and services to individuals. It also offers income tax return preparation services to its loan customers and other individuals. The Company operates 1,024 branches in Alabama, Georgia, Idaho, Illinois, Indiana, Kentucky, Louisiana, Mississippi, Missouri, New Mexico, Oklahoma, South Carolina, Texas, Tennessee, Utah, and Wisconsin.